SOPHiA GENETICS is excited to welcome you at our booth at ASCO24 and discuss topics such as:
- Unlocking the power of AI in kidney cancer research: UroCCR collaboration and UroPredict algorithm.
- Increasing access to liquid biopsy testing together with Memorial Sloan Kettering: Decentralizing MSK ACCESS powered with SOPHiA DDM™
- Leveraging Real-World Data to improve site selection, biomarker identification, and shorten enrolment cycles through access to the SOPHiA DDM™ Platform and its wealth of clinical data from across the globe.
- Outsourcing testing for HRD, DNA Damage pathways and others via the Integrated Access Mode to SOPHiA DDM™ Platform.
- Enhancing the reach of molecular testing with MaxCare Programs.
- SOPHiA DDM™ global network of cancer centers and institutions uniting in the fight against cancer.